The Impact of Inflammation on Pathological Processes

Authors

  • Riadh Hnewa Department of Pathology, College of Medicine, University of Warith Al Anbiyaa, Karbala, Iraq. Author
  • Duha Maithem Hassan Health and Medical Technical College. University of Al Zahraa for women- Iraq. Author

DOI:

https://doi.org/10.59675/M126

Keywords:

Acute Inflammation, pathological processes, Chronic Inflammation

Abstract

The term "inflammation" initially referred to a variety of well-known symptoms and signs, including erythema (redness), oedema, warmth, pain, and function loss (immobility and stiffness). Today, inflammation is understood to be a complicated, changing response to tissue damage brought on by noxious substances, certain environmental factors, trauma, infection or overuse. Some of these responses may be deleterious, as in many chronic disease states, while some could help with infection control and healing of wounds. Inflammation is a "second-line" defence against pathogenic microorganisms. The responses that inflammation causes are the basic processes of pathology. The suffix "-itis" denotes illnesses characterized by pathological inflammation. Cell-mediated and humoral immune system reactions largely produce inflammation. This study examines the association between inflammation and two major worldwide causes of death and morbidity: cardiovascular disease (CVD) and cancer.

References

Ansar W, Ghosh S, Ansar W, Ghosh S. Inflammation and inflammatory diseases, markers, and mediators: Role of CRP in some inflammatory diseases. In: Biology of C reactive protein in health and disease. 2016. p. 67-107. DOI: https://doi.org/10.1007/978-81-322-2680-2_4

Hawiger J, Zienkiewicz J. Decoding inflammation, its causes, genomic responses, and emerging countermeasures. Scand J Immunol. 2019;90(6):e12812. DOI: https://doi.org/10.1111/sji.12812

Karunaweera N, Raju R, Gyengesi E, Münch G. Plant polyphenols as inhibitors of NF-κB induced cytokine production—a potential anti-inflammatory treatment for Alzheimer's disease?. Front Mol Neurosci. 2015;8:24. DOI: https://doi.org/10.3389/fnmol.2015.00024

Gudkov AV, Komarova EA. p53 and the carcinogenicity of chronic inflammation. Cold Spring Harb Perspect Med. 2016;6(11):a026161. DOI: https://doi.org/10.1101/cshperspect.a026161

Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget. 2018;9(6):7204-18. DOI: https://doi.org/10.18632/oncotarget.23208

Rahimifard M, Maqbool F, Moeini-Nodeh S, Niaz K, Abdollahi M, Braidy N, et al. Targeting the TLR4 signaling pathway by polyphenols: a novel therapeutic strategy for neuroinflammation. Ageing Res Rev. 2017;36:11-19. DOI: https://doi.org/10.1016/j.arr.2017.02.004

Ablasser A, Chen ZJ. cGAS in action: Expanding roles in immunity and inflammation. Science. 2019;363(6431):eaat8657. DOI: https://doi.org/10.1126/science.aat8657

Alharbi KS, Fuloria NK, Fuloria S, Rahman SB, Al-Malki WH, Shaikh MAJ, et al. Nuclear factor-kappa B and its role in inflammatory lung disease. Chem Biol Interact. 2021;345:109568. DOI: https://doi.org/10.1016/j.cbi.2021.109568

Fitzgerald TL, Lertpiriyapong K, Cocco L, Martelli AM, Libra M, Candido S, et al. Roles of EGFR and KRAS and their downstream signaling pathways in pancreatic cancer and pancreatic cancer stem cells. Adv Biol Regul. 2015;59:65-81. DOI: https://doi.org/10.1016/j.jbior.2015.06.003

Tegowski M, Baldwin A. Noncanonical NF-κB in cancer. Biomedicines. 2018;6(2):66. DOI: https://doi.org/10.3390/biomedicines6020066

Kim EK, Choi EJ. Compromised MAPK signaling in human diseases: an update. Arch Toxicol. 2015;89:867-82. DOI: https://doi.org/10.1007/s00204-015-1472-2

Hotamisligil GS, Davis RJ. Cell signaling and stress responses. Cold Spring Harb Perspect Biol. 2016;8(10):a006072. DOI: https://doi.org/10.1101/cshperspect.a006072

Park HB, Baek KH. E3 ligases and deubiquitinating enzymes regulating the MAPK signaling pathway in cancers. Biochim Biophys Acta Rev Cancer. 2022;1877(3):188736. DOI: https://doi.org/10.1016/j.bbcan.2022.188736

Mullen M, Gonzalez-Perez RR. Leptin-induced JAK/STAT signaling and cancer growth. Vaccines (Basel). 2016;4(3):26. DOI: https://doi.org/10.3390/vaccines4030026

Morris R, Kershaw NJ, Babon JJ. The molecular details of cytokine signaling via the JAK/STAT pathway. Protein Sci. 2018;27(12):1984-2009. DOI: https://doi.org/10.1002/pro.3519

Jain M, Singh MK, Shyam H, Mishra A, Kumar S, Kumar A, et al. Role of JAK/STAT in the neuroinflammation and its association with neurological disorders. Ann Neurosci. 2021;28(3-4):191-200. DOI: https://doi.org/10.1177/09727531211070532

Chan DS, Bandera EV, Greenwood DC, Norat T. Circulating C-reactive protein and breast cancer risk—systematic literature review and meta-analysis of prospective cohort studies. Cancer Epidemiol Biomarkers Prev. 2015;24(10):1439-49. DOI: https://doi.org/10.1158/1055-9965.EPI-15-0324

Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. DOI: https://doi.org/10.3389/fimmu.2018.00754

Avan A, Tavakoly Sany SB, Ghayour-Mobarhan M, Rahimi HR, Tajfard M, Ferns G. Serum C-reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice. J Cell Physiol. 2018;233(11):8508-25. DOI: https://doi.org/10.1002/jcp.26791

Mantovani A. The inflammation–cancer connection. FEBS J. 2018;285(4):638-40. DOI: https://doi.org/10.1111/febs.14395

Hoppe C, Jacob E, Styles L, Kuypers F, Larkin S, Vichinsky E. Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial. Br J Haematol. 2017;177(4):620-9. DOI: https://doi.org/10.1111/bjh.14580

Bruno AS, Lopes PD, de Oliveira K, de Oliveira AK, de Assis Cau SB. Vascular inflammation in hypertension: targeting lipid mediators unbalance and nitrosative stress. Curr Hypertens Rev. 2021;17(1):35-46. DOI: https://doi.org/10.2174/1573402116666191220122332

Teixeira-Gomes A, Laffon B, Valdiglesias V, Gostner JM, Felder T, Costa C, et al. Exploring early detection of frailty syndrome in older adults: evaluation of oxi-immune markers, clinical parameters and modifiable risk factors. Antioxidants (Basel). 2021;10(12):1975. DOI: https://doi.org/10.3390/antiox10121975

Nagabhushana D, Mahesh KP. Chronic inflammation in oral cancer—adding fuel to fire. Turk J Physiother Rehabil. 2021;32(3):3.

Chavez-Dominguez R, Perez-Medina M, Aguilar-Cazares D, Galicia-Velasco M, Meneses-Flores M, Islas-Vazquez L, et al. Old and new players of inflammation and their relationship with cancer development. Front Oncol. 2021;11:722999. DOI: https://doi.org/10.3389/fonc.2021.722999

Published

26-05-2024

Issue

Section

Articles

How to Cite

Riadh Hnewa, & Duha Maithem Hassan. (2024). The Impact of Inflammation on Pathological Processes. Academic International Journal of Medical Sciences , 1(2), 34-43. https://doi.org/10.59675/M126